首页> 外文期刊>Southern Medical Journal >Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
【24h】

Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.

机译:获得耐碳青霉烯类肺炎克雷伯菌的医院感染的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Carbapenem-resistant Klebsiella pneumoniae (CRKP) has been increasingly reported all over the world. In this study, we aimed to investigate the risk factors for the acquisition of nosocomial CRKP infections. METHODS: We conducted a case-control study with data collected from thirty-nine patients with nosocomially acquired CRKP infection between July 2006 and July 2008. Controls were selected at a ratio of 1:2 from patients with nosocomial carbapenem-susceptible Klebsiella pneumoniae (CSKP) infection and were matched with CRKP cases for site of infection and the date of hospital admission (+/- within 5 days). T test, chi-square test, and logistic regression were used for statistical analysis. RESULTS: Bivariable analysis showed that the age of the patients (P=0.038), days of hospital stay prior to isolation of Klebsiella pneumoniae (K. pneumoniae) (P=0.043), altered consciousness (P=0.007), intensive care unit (ICU) admission within two weeks (P=0.003), tracheal intubation (P=0.027), mechanical ventilation (P=0.009), number of changes in antibiotics>/=4 (P=0.001), exposure to carbapenems (P = 0.002), exposure to fourth-generation cephalosporins (P=0.027), and exposure to piperacillin-tazobactams/cefoperazone-sulbactams (P=0.043) and glycopeptides (P=0.042) were related to CRKP infection. The multivariable analysis showed that ICU admission (within two weeks) [odds ratio (OR):4.68, 95% confidence intervals (CI):1.15-19.09, P=0.031], exposure to carbapenems (OR: 12.69, 95% CI: 2.09-77.10, P=0.006) and exposure to glycopeptides (OR: 3.57, 95% CI: 1.11-11.42, P=0.032) were independent risk factors for nosocomial CRKP infections. CONCLUSION: Several factors are related to CRKP infections. ICU admission (within two weeks) or prior exposure to carbapenems or glycopeptides are independent risk factors for the acquisition of nosocomial CRKP infections.
机译:目的:耐碳青霉烯的肺炎克雷伯菌(CRKP)已在世界范围内得到越来越多的报道。在这项研究中,我们旨在调查院内CRKP感染获得的危险因素。方法:我们进行了一项病例对照研究,收集了2006年7月至2008年7月间39例院内获得性CRKP感染患者的数据。按1:2的比例从院内碳青霉烯易感性肺炎克雷伯菌患者(CSKP)中选择对照)感染,并与CRKP病例相匹配,以了解感染部位和入院日期(+/- 5天内)。使用T检验,卡方检验和逻辑回归进行统计分析。结果:双变量分析显示患者的年龄(P = 0.038),分离肺炎克雷伯菌(K.pneumoniae)之前的住院天数(P = 0.043),意识改变(P = 0.007),重症监护病房(P = 0.007)。 ICU)两周内入院(P = 0.003),气管插管(P = 0.027),机械通气(P = 0.009),抗生素变化次数> / = 4(P = 0.001),接触碳青霉烯(P = 0.002) ),接触第四代头孢菌素(P = 0.027)和接触哌拉西林-他唑巴坦/头孢哌酮-舒巴坦(P = 0.043)和糖肽(P = 0.042)与CRKP感染有关。多变量分析显示,ICU入院(两周之内)[几率(OR):4.68,95%置信区间(CI):1.15-19.09,P = 0.031),接触碳青霉烯类药物(OR:12.69,95%CI: 2.09-77.10,P = 0.006)和暴露于糖肽(OR:3.57,95%CI:1.11-11.42,P = 0.032)是院内CRKP感染的独立危险因素。结论:与CRKP感染有关的几个因素。 ICU入院(两周之内)或事先接触碳青霉烯或糖肽是获得院内CRKP感染的独立危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号